Merck Reports Surging Sales of Vaccines and Key Cancer DrugMerck Reports Surging Sales of Vaccines and Key Cancer DrugMerck posted revenue of $10.82 billion in the period, up 8% from 2018's first quarter.Associated PressAssociated Press